Skip to main content
Roger Blumenthal, MD, Cardiology, Lutherville, MD

Roger Scott Blumenthal MD FACC, FAHA, FNLA

Cardiology•Lutherville, MD

Professor of Medicine, Johns Hopkins University School of Medicine; Director of Johns Hopkins Ciccarone Center for the Prevention of Heart Disease

Join to View Full Profile

  • 10755 Falls RoadPavilion I Ste 360Lutherville, MD 21093

  • Phone+1 443-997-0270

  • Fax+1 410-367-2448

Dr. Blumenthal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Blumenthal's Full ProfileAlready have an account?

Summary

  • I am the Director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. I was Co-Chair of the AHA/ACC Subcommittee that oversaw the Hypertension, Cholesterol, Risk Assessment and Primary Prevention of Cardiovascular Disease Guidelines from 2015-2019.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2002
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1988 - 1992
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1988
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1985
  • Johns Hopkins University
    Johns Hopkins UniversityB.A., Natural Sciences, 1977 - 1981

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1986 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Top Doctors:Baltimore Area Castle Connolly, 2012-2021
  • America's Top Doctors Castle Connolly, 2001-2021
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk Factors  
    Seamus P Whelton, John W Mcevoy, Matthew Budoff, Khurram Nasir, Roger S Blumenthal, Michael J Blaha, JAMA Cardiology
  • Clinical Research Adiposity and Incident Heart Failure and Its Subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)  
    Roger S Blumenthal, Erin D Michos, Mary Cushman, Matthew A Allison, Kavita Sharma, Michael H Criqui, ScienceDirect
  • Review Article Communication Issues in Nutritional Observational Research  
    Michael J Blaha, Roger S Blumenthal, John W McEvoy, ScienceDirect
  • Join now to see all

Lectures

  • Results from EVAPORATE Trial Suggest That Cardioprotective Benefits of Eicosapentaenoic Acid (EPA) Are Related to Plaque Reduction and Stabilization 
    The Johns Hopkins University School of Medicine, Baltimore, Maryland - 6/28/2012
  • Facts or Alternate Facts: A Case-Based Deep Dive Into the Recently Released Prevention Guidelines 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Late-Breaking Clinical Trials 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Join now to see all

Authored Content

  • A Remote Technology-Enabled, Algorithm-Guided Program to Improve Health Equity in Hypertension and LDL-C ManagementFebruary 2022
  • Cardiovascular Health in Early Life: Sign of What's to Come?October 2021
  • Identifying the Roadblocks to Engagement of Women in Clinical TrialsOctober 2021
  • Statin Therapy Allocation in Intermediate Risk PopulationSeptember 2021
  • Update in Prevention: 2021 Canadian Cardiovascular Society Dyslipidemia GuidelinesSeptember 2021
  • Use of Cardiac CT to Improve Medical Management in Adults with Diabetes: CAC in the Asymptomatic Patient (Part I)November 2020
  • Approaching Statin Therapy in Adults with and Without DiabetesOctober 2020
  • CCTA as a Tool for Prevention in Patients with Stable Chest PainSeptember 2020
  • Outcomes of Acute Myocardial Infarction Hospitalizations During the COVID-19 PandemicAugust 2020
  • Outcomes of Acute Myocardial Infarction Hospitalizations During the COVID-19 PandemicAugust 2020
  • Comparison of Dietary and Exercise Recommendations on Both Sides of the AtlanticAugust 2020
  • Non-Invasive Assessment of Myocardial ViabilityAugust 2020
  • Bempedoic Acid for LDL-C Lowering: What Do We Know?August 2020
  • Determining the Role of Coronary Artery Disease Severity Measured by Coronary CTA in ASCVD Risk ManagementJuly 2020
  • Continuing Preventive Care During the COVID-19 Pandemic: Discussion of Recent ASPC RecommendationsJuly 2020
  • Continuing Preventive Care During the COVID-19 Pandemic: Discussion of Recent ASPC RecommendationsJuly 2020
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Impressive Data on Prognostic Importance of Lipids May Lead to Earlier Prescription in Those with High Long-Term ASCVD Risk EstimatesJanuary 2020
  • Impressive Data on Prognostic Importance of Lipids May Lead to Earlier Prescription in Those with High Long-Term ASCVD Risk EstimatesJanuary 2020
  • Reporting the Clinical Value of Cardiovascular Risk FactorsFebruary 2019
  • Statin Safety and Adverse EventsDecember 2018
  • New Data on Aspirin Use in the Era of More Widespread Statin UseSeptember 2018
  • Astro-CHARM, the First 10-Year ASCVD Risk Estimator Incorporating Coronary CalciumAugust 2018
  • Impact of C-reactive Protein and Coronary Artery Calcium on Benefit Observed with AtorvastatinMay 2018
  • The Prognostic Value of High Sensitivity C-reactive Protein in a Multi-Ethnic Population After >10 Years of Follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA)May 2018
  • 10-Year Resource Utilization and Costs for Cardiovascular CareMarch 2018
  • Join now to see all

Press Mentions

  • Blood Tests Can Help Predict Heart Disease Risk over Next 3 Decades
    Blood Tests Can Help Predict Heart Disease Risk over Next 3 DecadesSeptember 5th, 2024
  • Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events
    Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV EventsAugust 31st, 2024
  • Wait, Are People over 60 Supposed to Take Aspirin for Heart Health or Not?
    Wait, Are People over 60 Supposed to Take Aspirin for Heart Health or Not?August 7th, 2024
  • Join now to see all

Grant Support

  • Cholesterol Lowering By Nurses To Control Heart DiseaseNational Center For Research Resources2000–2002

Research History

  • Director, Johns Hopkins Ciccarone CenterOur research has focused on cost-effective ways to improve cardiovascular risk prediction and optimize patient-centered cardiac care. in the primary and secondary prevention settings.

Professional Memberships

External Links

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Roger Blumenthal, Dr. Roger Blumenthal, MD, Dr. R Blumenthal, Dr. Roger Scott Blumenthal